TRIP12 and neoplasm: Furthermore, proteomic analysis of MIR503HG revealed other E3 ubiquitin ligases, such as TRIM4, PJA1 and TRIP12, which have been demonstrated to inhibit tumour progression in breast cancer and NSCLC.46, 47, 48